Latest Supply Agreements News

Evion Group is advancing the Stage 2 expansion of its expandable graphite facility in India to boost production capacity amid rising demand from Europe, the USA, and Asia. The upgrade aligns with the EU’s recognition of graphite as a critical mineral, positioning Evion as a key supplier in strategic sectors.

NH3 Clean Energy has locked in a crucial 15-year water supply agreement with the Water Corporation of WA for its flagship WAH2 clean ammonia project, marking a key step towards its final investment decision.

Horizon Minerals has completed mining at Boorara and plans to use its substantial ore stockpiles to support the mid-2027 commissioning of the Black Swan Processing Hub, aiming for a smooth production restart in early 2027.

OMG Group has launched two new matcha brands targeting both premium and mass-market consumers, supported by a five-year exclusive supply agreement for ceremonial-grade Japanese matcha. This move positions OMG to capitalise on the booming global matcha market through a vertically integrated strategy.

Lynas Rare Earths and Japan Australia Rare Earths B.V. have extended their supply agreement to 2038, securing firm commitments for critical rare earths with a pricing floor and upside sharing mechanism.

Metallium Limited reports rapid progress at its Gator Point Technology Campus in Texas, advancing its proprietary Flash Joule Heating technology to recover critical metals from electronic waste. The company targets processing 8,000 tonnes of printed circuit boards annually by late 2026.

OMG Group has secured a national extension with Woolworths to launch three new high-protein oat milk flavours, aiming to capitalise on growing consumer demand and boost FY26 revenue.

Memphasys Limited has advanced its Felix™ System commercial rollout with key regulatory approvals and new international contracts, while trimming operating costs and narrowing losses in the first half of FY2026.

Lumos Diagnostics reported a 74% increase in its half-year loss to US$4.88 million, despite strong progress with its FebriDx diagnostic test and a landmark US distribution agreement. The company awaits a critical FDA decision that could unlock significant revenue growth.

Sprintex Limited reported a 162% surge in revenue to A$2.7 million for the half-year ending December 2025, driven by a landmark €15.6 million European contract. Despite this, the company posted a net loss of A$1.7 million, an improvement from the prior year, while raising $3.6 million to support global expansion.

Tetratherix Limited reported a $4.6 million statutory loss for the first half of FY26, driven by increased R&D and manufacturing investments, while making significant progress in clinical trials and securing key global partnerships.

Coronado Global Resources reported a $432.1 million net loss for FY2025, impacted by a 22% revenue decline due to softer metallurgical coal markets and logistical challenges. Despite operational gains and cost cuts, the company strengthened liquidity through refinancing and support from Stanwell.